23ANDME PERSONAL GENOME SERVICE (HEREINAFTER KNOWN AS PGS)

Autosomal Recessive Carrier Screening Gene Mutation Detection System

23andMe

The following data is part of a De Novo classification by 23andme with the FDA for 23andme Personal Genome Service (hereinafter Known As Pgs).

Pre-market Notification Details

DeNovo IDDEN140044
Device Name:23ANDME PERSONAL GENOME SERVICE (HEREINAFTER KNOWN AS PGS)
ClassificationAutosomal Recessive Carrier Screening Gene Mutation Detection System
Applicant 23andMe 1390 Shorebird Way Mountain View,  CA  94043
ContactKathy Hibbs
Product CodePKB  
CFR Regulation Number866.5940 [🔎]
DecisionGranted (DENG)
510(k) Premarket NotificationDevice Classification Under Section 513(f)(2)(de Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin
Review Advisory BoardClinical Chemistry
Classification AdvisoryImmunology
TypeDirect
Date Received2014-05-29
Decision Date2015-02-19
FDA ReviewDecision Summary
Reclassification Order:Reclassification Order

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00859462006095 DEN140044 000
00859462006279 DEN140044 000
00859462006262 DEN140044 000
00859462006378 DEN140044 000
00859462006385 DEN140044 000
00859462006392 DEN140044 000
00859462006408 DEN140044 000
00859462006415 DEN140044 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.